• Chlorpromazine: Mechanistic and Application Benchmarks in Re

  2026-06-02

  Chlorpromazine is a validated phenothiazine antipsychotic, well-characterized as a dopamine D2 receptor antagonist. Its broad research uses—from schizophrenia modeling to antiemetic studies—are supported by robust benchmarks and high-purity supply from APExBIO.

• FGFR and PI3K/AKT Cross Talk Regulates Periostin in Breast C

  2026-06-02

  This study uncovers how periostin expression in HER2-positive breast cancer cells is regulated through intricate cross talk among FGFR, TGFβ, and PI3K/AKT pathways. The findings clarify mechanistic details of periostin induction and suppression, with implications for targeting PI3K/Akt/mTOR signaling in aggressive breast cancer subtypes.

• Estrogen Drives PTC Progression via ERα/KRT19 Signaling Axis

  2026-06-01

  This study delineates how estrogen promotes the proliferation, migration, and invasion of papillary thyroid carcinoma (PTC) cells through an ERα/KRT19 signaling mechanism. Integrating transcriptomic, bioinformatic, and functional assays, the work provides a mechanistic bridge between epidemiological patterns and cellular drivers of PTC, highlighting new molecular targets for research and potential intervention.

• Fosinopril Sodium in ACE Inhibitor Research: Workflows & Opt

  2026-06-01

  Fosinopril sodium, a phosphinic acid ACE inhibitor, offers dual renal and hepatic elimination—enabling robust hypertension and cardiovascular disease models. Discover advanced experimental workflows, data-driven troubleshooting, and translational tips to maximize reproducibility in blood pressure and renal hemodynamics research.

• BIBR 1532 Telomerase Inhibitor: Precision Tools for Cancer R

  2026-05-31

  BIBR 1532 empowers researchers with highly selective, quantifiable inhibition of telomerase, providing a robust platform for dissecting telomere-dependent oncogenic mechanisms. This article translates recent mechanistic advances—including synergy with emerging therapies—into practical workflows, troubleshooting insights, and next-level assay strategies.

• Biotin-HPDP in Palmitoylation and Immune Microenvironment Ma

  2026-05-30

  Explore the advanced use of Biotin-HPDP in dissecting protein palmitoylation and immune microenvironment dynamics. This article provides expert analysis, protocol insights, and unique perspectives on thiol-specific protein labeling for complex cancer and immunology research.

• Vorinostat (SAHA): Apoptotic Pathways and Epigenetic Insight

  2026-05-29

  Explore the mechanistic depth of Vorinostat (suberoylanilide hydroxamic acid) in apoptosis and epigenetic modulation, with new insights from recent apoptotic pathway discoveries. This article offers a unique, evidence-driven perspective for advanced cancer biology research.

• Berberine Hydrochloride: Gut-Bone Axis and Translational Inn

  2026-05-29

  This article synthesizes the gut-bone axis paradigm with mechanistic and strategic insights for translational researchers, centering on Berberine hydrochloride’s multifaceted roles in metabolism and osteoimmunology. By integrating recent findings on tuft cell expansion and butyrate signaling with established AMPK and anti-apoptotic pathways, this piece delineates a framework for experimental design and clinical translation, while spotlighting APExBIO’s high-purity Berberine hydrochloride as a research catalyst.

• Dexamethasone: Glucocorticoid Anti-Inflammatory in Translati

  2026-05-28

  Dexamethasone (DHAP) from APExBIO is a synthetic glucocorticoid anti-inflammatory trusted for dissecting NF-κB signaling, stem cell differentiation, and neuroinflammation. This guide delivers actionable protocol enhancements, troubleshooting tips, and comparative insights to maximize research outcomes while bridging the latest reference advances into applied experimental design.

• EGCG Nanoparticles Enhance FLASH-RT-Induced DNA Damage in Tu

  2026-05-28

  This study introduces self-assembled EGCG nanoparticles (BENPs) as radiosensitizers that amplify the antitumor efficacy of ultra-high dose rate radiotherapy (FLASH-RT) by promoting reactive oxygen species production and DNA double-strand breaks. The findings provide mechanistic insight into how BENPs enhance tumor cell killing and stimulate antitumor immune responses, supporting future optimization of radiotherapy protocols.

• FPH1 (BRD-6125): Optimizing Hepatocyte Proliferation Assays

  2026-05-27

  FPH1 (BRD-6125) uniquely empowers functional expansion of primary human hepatocytes, enabling scalable, donor-independent culture workflows. Explore data-backed protocols, troubleshooting, and integration strategies that set new standards for reliable hepatocyte assays and regenerative medicine.

• Chlorambucil: Optimizing Alkylating Agent Workflows in Cance

  2026-05-27

  Chlorambucil's unique DNA crosslinking and apoptosis induction profile makes it indispensable for reproducible cytotoxicity assays in cancer research. This article delivers actionable workflows, troubleshooting tips, and strategic assay enhancements that leverage APExBIO's high-purity Chlorambucil for robust and reliable experimental outcomes.

• Differential Volatile Profiles of Chuanxiong in CHD: Role of

  2026-05-26

  This study utilizes advanced metabolomics and network pharmacology to reveal distinct volatile profiles and mechanistic targets in the cortex and pith of Ligusticum chuanxiong for coronary heart disease (CHD) intervention. Fenipentol emerges as a key bioactive component, suggesting new avenues for targeted gastrointestinal and cardiovascular research.

• Hydroxytyrosol in Translational Research: Beyond Cardiovascu

  2026-05-26

  Explore how Hydroxytyrosol, a potent antioxidant bioactive compound, advances translational research by bridging mechanistic insights and assay optimization. Uncover nuanced guidance for experimental design and practical research applications.

• Ziprasidone Hydrochloride: Advanced Mechanisms in Oncology R

  2026-05-25

  Explore the multifaceted roles of Ziprasidone Hydrochloride in modern oncology and neuroscience research. This article uncovers the antitumor mechanisms, impurity profiling, and translational assay strategies that set this second-generation antipsychotic apart.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page